DIVISION OF PULMONOLOGY

Faculty

Dr. Donna Beth Willey-CourandDonna Beth Willey-Courand, MD

Clinical Professor of Pediatrics and Division Chief
Miss Eloise Alexander Distinguished University Chair in Pediatric Pulmonology
Director, UTHSCSA Cystic Fibrosis Center
Robert B. Green Clinical Pavilion, University Health System
Division of Pediatric Pulmonology
210-562-5844

Education
M.D., University of Maryland School of Medicine, 1992
B.S., chemistry, Duke University, 1988

Training
Fellowship, Pediatric Pulmonary, Massachusetts General Hospital, Boston, 1995-1998
Fellowship, Biomedical Engineering, Massachusetts General Hospital, Boston, 1996-98
Residency, Pediatrics, Baylor College of Medicine, 1993-95
Internship, Pediatrics, Baylor College of Medicine, 1992-93

Board Certification
Pediatrics, 1995;
Pediatric Pulmonology, 2000

Completed Clinical Trials
A Multicenter, Double-Blind Placebo-Controlled Randomized, Efficacy and Safety Study of Denafusal, Telrasodium (INS372171) Inhalation Solution in Patients with Mild Cystic Fibrosis Lung Disease.

Antimicrobial Resistence in Sputum, Obtained from Patients with Cystic Fibrosis (Under CHRISTUS Santa Rosa Children's Hospital IRB Review)

Stool Elastase in Patients with Cystic Fibrosis, Misclassification of Patients Having Insufficient Pancreatic Exocrine Function

Long Term Administration of Inhaled Mannitol in Cystic Fibrosis, A Safety and Efficacy Study

A Randomized, Open Label Multicenter, Phase 3, Trial to Assess the Safety of Tobramycin Inhalational Powder Compared to TOBI® in Cystic Fibrosis Subjects

Ongoing Clinical Research
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients Treated with Pancreatic Enzyme Replacement Therapy.

Ongoing Grant Support
Cystic Fibrosis Center Award
2016 CSHCN – Children with Special Health Care Needs, Case Management Award.  Grant focused on case management and the development of a medical home for patients with cystic fibrosis.

Other Activity
Serves as member of Cystic Fibrosis Foundation Center Committee.
Member of Cystic Fibrosis Foundation Guidelines Committee to develop clinical recommendations for the use of genetic modifier therapies to treat patients with cystic fibrosis.

Publications
Rayas MS, Willey-Courand DB, Lynch JL, Guajardo JR. Improved Screening for Cystic Fibrosis-Related Diabetes by an Integrated Care Team Using an Algorithm Pediatric Pulmonology 2014 Oct;49(10):971-977.
Brown RF, Willey-Courand DB, George C, McMullen A, Duntz J, Solvis B, Perkett E. Non-Physician Providers as Clinical Providers in Cystic Fibrosis: Survey of US Programs; Pediatric Pulmonology 2013 Apr;4(48):398-404.

Flume PA, O‘Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, Marshall B. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007 Nov;176(10):957-969.

Campbell Jr RM, Smith MD, Mangos JA, Willey-Courand DB, Kose N, Pinero RF, Alder ME, Duong HL, Surber JL. The Effect of Opening Wedge Thoracostomy on Thoracic Insufficiency Syndrome Associated with Fused Ribs and Congenital Scoliosis. J Bone Joint Surg Am 2004 Aug;86-A(8):1659-1674.

Campbell RM, Smith MD, Mayes TC, Mangos JA, Willey-Courand DB, Kose N, Pinero RF, Alder ME, Duong HL, Surber JL. The characteristics of thoracic insufficiency syndrome associated with fused ribs and congenital scoliosis. J Bone Joint Surg Am 2003 Mar;85-A(3):399-408.

Willey-Courand DB, Harris RS, Galletti GG, Hales CA, Fischman A, Venegas JG. Alterations in regional ventilation, perfusion, and shunt after smoke inhalation measured by PET. J Appl Physiol 2002 Sep;93(3):1115-1122.

Harris RS, Willey-Courand DB, Head CA, Galletti GG, Call DM, Venegas JG. Regional VA, Q, and VA/Q during PLV: effects of nitroprusside and inhaled nitric oxide. J Appl Physiol 2002 Jan;92(1):297-312.

Willey-Courand DB, Rayas, MS. Improved Screening and Care for Patients with Cystic Fibrosis-Related Diabetes (CFRD) at CHRISTUS Santa Rosa Childrens Hospital, Cystic Fibrosis Center (CSRCHCFC): A Quality Improvement Initiative; 2011 Jan. (Pediatric Pulmonology; vol. suppl, no. 34).

Willey-Courand DB, George C, McMullen A, Hazle L, Danish M, Dunitz J, Yankaskas J, Perkett E. Non-Physician Provides (NPP): Roles in CF Care Wiley-Blackwell; 2009 Oct. p. 431-432. (Pediatric Pulmonology).

Willey-Courand DB, Rayas, Maria S., Lynch JL. CFRD: A current review of screening, diagnosis, and treatment. 2009 Southern Regional Conference in New Orleans, LA 2009 Feb.

Willey-Courand DB, Inscore SC, Hentschel-Franks KA, Mendoza P, Drummond M, Branstetter A. Improving The Nutritional Status of Pediatric Patients at CHRISTUS Santa Rosa Children‘s Hospital Cystic Fibrosis Center 2005. p. 342. (Pediatric Pulmonology; vol. Suppl, no. 28).

Campbell RM, Willey-Courand DB, Smith MD, Mangos JA. The incidence of proximal cervical spine stenosis in Jeune‘s asphyxiating thoracic dystrophy in the report of a case of diaphragmatic paralysis due to spinal cord compression 2001 May. p. A31. (Am J Resp Crit Care Med; vol. 163, no. 5).

Willey-Courand DB, Mangos JA, Mayes TC, Smith MD, Campbell RM. Implantation of Vertical Expandable Prosthetic Titanium Ribs (VEPTR) Halts the Progression of the Thoracic Insufficiency Syndrome (TIS) (Supplement) Part 2; 1999 Mar. p. A780. (Am J of Resp Crit Care Med; vol. 159, no. 3).

Harris RS, Willey-Courand DB, Kwo J, Venegas JG. Nitric Oxide (NO) Uptake in Lung Lavage (LL) and Pulmonary Artery Occlusion (Supplement) Part 2; 1999 Mar. p. A220. (Am J Resp Crit Care Med; vol. 159, no. 3).

Willey-Courand DB, Harris R, Galletti G, Hales C, Venegas J. Alterations of Regional Ventilation and Perfusion After Smoke Inhalation (Supplement) Part 2; 1998 Mar. p. A367. (Am J Resp Crit Care Med; vol. 157, no. 3).

Willey-Courand DB, Harris R, Galletti G, Head C, Venegas J. Partial Liquid Ventilation (PLV) Reduces Shunt (Qs/Qt) in the Surfactant Deficient Lung (Supplement) Part 2; 1998 Mar. p. A464. (Am J Resp Crit Care Med; vol. 157, no. 3).

Harris RS, Willey-Courand DB, Head CA, Galletti GG, Venegas JG. The Effects of Pulmonary Vasodilation on Regional Pulmonary Perfusion (Qr) and Ventilation (Var) During Partial Liquid Ventilation (PLV) (Supplement) Part 2; 1998 Mar. p. A462. (Am J Resp Crit Care Med; vol. 157, no. 3).

Willey-Courand DB, Kirmse M, Fujino Y, Nathan N, Venegas J, Kacmarek R, Head CA. Alterations in Cardiovascular Function During Partial Liquid Ventilation (PLV) as Detected by Echocardiography (Supplement) Part 2; 1998 Mar. p. A528. (Am J Resp Crit Care Med; vol. 157, no. 3).

Venegas JG, Harris RS, Galletti G, Willey-Courand DB, Head CA. Partial Liquid Ventilation (PLV) Decreases Shunt and Not Perfusion to Dependent Lung Regions in Oleic Acid Induced ARDS (Supplement) Part 2; 1997 Apr. p. A745. (Am J Resp Crit Care Med; vol. 155, no. 4).

Willey-Courand DB, Marshall BC. Cystic Fibrosis In: McInerny TK, Adam HM, Campbell D, Kamat DK, Kelleher KJ, eds.. Pediatric Primary Care. Elk Grove Village, IL 2009 (Second Edition Currently in Press).

Willey-Courand DB. Parent Handbook - Clinical Teaching of Basic Pathophysiology of Chronic Lung Disease and Care of the Affected Infant 1998.

Willey-Courand DB, Rayas, MS. Rayas MS, Willey-Courand, DB, Improved Screening and Care for Patients with Cystic Fibrosis - Related Diabetes (CFRD) at CHRISTUS Santa Rosa Children‘s Hospital, Cystic Fibrosis Center (SRCHCFC) A Quality Improvement Initiative. 2011;34.

Willey-Courand DB, Matasovsky, L. Cystic Fibrosis: Etiology, Genetics and Diagnosis. Online Module for mid level providers. https://portcf2dev.cff.org/ProviderEducation/midlevel.html 2012.

Willey-Courand, Donna Beth (I am listed as an investigator for the study in the appendix). Authors of article as follows: Drucy Borowitz MD, Susan S. Baker MD, PhD, Linda Duffy, PHD, Robert D. Baker, MD, PHD, Larura Fitzpatrick, MSN, FNP, Joyce Gyamfi, MS, and Kerry Jarembek, BS. Use of Fecal Elastase-1 To Classify Pancreatic Status in Patients With Cystic Fibrosis Journal of Pediatrics2004;145:322-326.

Interests
Clinical – Optimization of care for patients with cystic fibrosis through participation in quality improvement initiatives and participation in clinical trials.

Research - Involvement in multicenter drug studies with various cystic fibrosis specific therapies.

 

 

Jesus R. Guajardo, M.D., Ph.D.Jesus R. Guajardo, MD, PhD

Associate Professor of Pediatrics
Associate director, UTHSCSA Cystic Fibrosis Center
The Robert B. Green Clinical Pavilion, University Health System
Director Pediatric Residency Education and Curriculum
Division of Pediatric Pulmonology
210-562-5844

Education
Ph.D., Doctor of Philosophy, University of Missouri-Columbia, 2012
M.D., medicine, Ignacio A. Santos School of Medicine, Monterrey, N.L., Mexico, 1994
M.H.P.E, University of Illinois, Chicago, IL, USA, 1999

Training
Fellowship, Allergy/Immunology and Pediatric Pulmonology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, 1999-03
Residency, Pediatrics, University of Illinois at Chicago, Chicago, IL, 1997-99
Internship, Pediatrics, University of Illinois at Chicago, Chicago, IL, 1996-97

Board Certification
Pediatric Pulmonology, 2004
Allergy & Immunology, 2003
Pediatrics, 1999

Clinical Research Completed
Mycoplasma pneumoniae in patients with cystic fibrosis

Publications
Rayas MS, Willey-Courand DB, Lynch JL, Guajardo JR. Improved Screening for Cystic Fibrosis-Related Diabetes by an Integrated Care Team Using an Algorithm. Pediatric Pulmonology 2014 Oct;49(10):971-977.

Griffard EA, Guajardo JR, Cooperstock MS, Scoville CL. Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient. Pediatr Pulmonol2010 May;45(5):508-510.

Finstad K, Guajardo JR, Scoville C. Neuralgic amyotrophy associated with antibiotic therapy. Ann Pharmacother 2008 Sep;42(9):1344-13.

Jacobs ZD, Guajardo JR, Anderson KM. XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol 2008 Aug;30(8):631-634.

Assa‘ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, Buckmeier BK, Bullock JZ, Collier AR, Konikoff MR, Noel RJ, Guajardo JR, Rothenberg ME. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 2007 Mar;119(3):731-738.
Cogar BD, Groshong TD, Turpin BK, Guajardo JR. Chylothorax in Henoch-Schonlein purpura: a case report and review of the literature. Pediatr Pulmonol2005 Jun;39(6):563-567.

Guajardo JR, Schleifer KW, Daines MO, Ruddy RM, Aronow BJ, Wills-Karp M, Hershey GK,. Altered gene expression profiles in nasal respiratory epithelium reflect stable versus acute childhood asthma. J Allergy Clin Immunol 2005 Feb;115(2):243-251.

Noel RJ, Putnam PE, Collins MH, Assa‘ad AH, Jameson SC, Rothenberg ME, Guajardo JR. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004 Jul;2(7):568-575.

Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME. Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr 2002 Oct;141(4):576-581.

Amin Z, Guajardo J, Wisniewski W, Bordage G, Tekian A, Niederman LG. Morning report: focus and methods over the past three decades. Acad Med2000 Oct;75(10 Su):1-5.

Jacobs ZD, Guajardo JR, Guajardo J. Intubation secondary to asthma exacerbation in a patient with asthma receiving Xolair (omalizumab). Pediatr Pulmonol 2008 Jan;43(1):102-103.

Other
Guajardo JR, Assa’ad AH, Jameson S, Collins MH, Putnam PE, Noel R, Rothenberg, ME. An International Registry of Patients with Eosinophilic Esophagitis. 2003 Jan.

Interests
Committed to clinical research, medical education, bronchoscopy, and allergy/immunology disorder.

 

 

Filomena Hazel Villa M.DFilomena Hazel Villa MD

Assistant Professor of Pediatrics
Miss Eloise Alexander Chair in Pediatric Pulmonary Diagnostics and Evaluation
Division of Pediatric Pulmonology
210-562-5844

Education
M.D., University of the East Ramon Magsaysay Memorial Medical Center Quezon City, Philippines, 1986
B.S., Zoology, University of the Philippines at Los Banos, Laguna, Philippines, 1982

Training
Fellowship, Pediatric Pulmonary, Children’s Hospital Research Center, Oakland, 2009-2012
Fellowship, Pediatric Pulmonary, University of the Philippines, 1993-1995
Residency, Pediatrics, Texas Tech Health Sciences Center, El Paso, 2006-2009
Residency, Pediatrics, Manila Doctors Hospital, Philippines, 1990-1993
Residency, Pediatrics, Pre-Residency training at Manila Doctors Hospital, Ermita, Manila, Philippines, 1989-1989

Board Certification
Pediatrics, 2009
Pediatric Pulmonology, 2012

Publications
Marie Leiner, PhD, Hazel Villa, MD, Namrata Singh, MD, Irma Medina, MD, Pratibha Shirsat, MD.. Pregnant Teenagers and Teenage Mothers: How Much They Really Know About the Risks to Children‘s Health Associated with Smoking During and after Pregnancy Journal School of Health (Official Journal of the American School Health Association 2007 Mar;77(2007).

Milagros Untalan, MD, Filomena Hazel Villa, MD. The Effect of Procaterol A Long Acting Brochodilator in Airway Hyperresponsiveness in Children American Journal of Respiratory and Critical Care Medicine 1997;155(4).

Interests
Clinical research, pulmonary function tests, chronic lung disease, outpatient  ventilator management, flexible bronchoscopy/airway evaluation.

 

 

Stacey Denver, MSN, PNPStacey Denver, M.S.N., R.N., F.N.P-B.C.

Family Nurse Practitioner
Instructorand Director of Clinic Operations
Robert B. Green Clinical Pavilion, University Health System
Division of Pediatric Pulmonology
210-562-5844

Education
B.S., nursing, UT Health Science Center San Antonio, 1990
M.S., nursing, UT Health Science Center San Antonio, 2002
D.N.P., doctor of nursing practice, Vanderbilt University, Nashville, TN, 2014

Board Certification
Texas, family nurse practitioner, 2002
Texas, registered nurse, 1990

Publications
Gochuico BR, Huising M, Golas GA, Scher CD, Tsokos M, Denver S, Frei-Jones MJ, Gahl WA. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease. Molecular Medicine 2012 Feb;10(18):56-64

Interests
Working with families and children with asthma, cystic fibrosis, sleep disorders, and other chronic pulmonary diseases.

 

 

MatasovskyLisa J. Lunsford, D.N.P., R.N., P.N.P., PC/AC

Pediatric Nurse Practitioner
Assistant Professor/Clinical
Newborn Screening Coordinator, UTHSCSA Cystic Fibrosis Center
The Robert B. Green Clinical Pavilion, University Health System
Division of Pediatric Pulmonology
210-562-5844

Education
B.S., Nursing, Bethel University, St. Paul, 1997
M.S., Nursing, University of Minnesota, Minneapolis, 2007
Post Masters Nursing, AC-PNP, Vanderbilt University, Nashville, 2011
D.N.P., Doctor of Nursing Practice, Vanderbilt University, Nashville, 2012

Training
Clinical fellowship, pediatric pulmonology, University of Wisconsin, Madison, 1996-98

Board Certification
Minnesota, registered nurse, 1996
Texas, registered nurse, 2007
Texas, pediatric nurse practitioner, 2007

Ongoing Clinical Research
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients Treated with Pancreatic Enzyme Replacement Therapy

Publications
Lunsford L. Knowledge and Attitudes Regarding Pediatric Pain in Mongolian Nurses Elsevier Inc.; 2015 Jun. p. 346-353. (American Society of Pain Management Nursing; vol. 16, no. 3).

Matasovsky LJ,APN-PNP ;Britton, L,APN-FNP; Cotton, C. ,APN-FNP; Davies, Z., APN-PNP; Fries, L., PA-C, MPAS, DPT; George, C., APN-ANP; McMullen, A., APN-PNP; Ramsay, M., APN-ANP; Rasmussen, LyN., APN-FNP; Rodgers, T., APN-PNP; Singh, C., APN-ANP; Tomczyk, C., APN-PNP; Ulles, M., APN-PNP; VandenBranden, S., APN-PNP; Zirbes, J, APN-PNP. The Role of the Nurse Practitioner or Physician Assistant in Cystic Fibrosis Center Care Cystic Fibrosis Foundation 2011 Feb.

Interests
Clinical - Implementation and coordination of cystic fibrosis newborn screening for Southern Texas. Working with children and families with special health care needs such as chronic lung disease, asthma, neuromuscular diseases and cystic fibrosis.

Community - Active participation in global health issues such as asthma and congenital heart disease to underserved areas of the world.